Associated Papers
Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.
Khorshied M et al.
Cancer Biomarkers : Section a of Disease Markers, 2021
Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R et al.
Cellular and Molecular Biology (noisy-le-grand, France), 2015
There is no significant association between death receptor 4 (DR4) gene polymorphisms and lung cancer in Turkish population.
Taştemir-Korkmaz D et al.
Pathology Oncology Research : Por, 2013
Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer.
Horak P et al.
Gynecologic Oncology, 2005
Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms.
Fernàndez V et al.
Haematologica, 2004
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma.
Lee SH et al.
Oncogene, 2001
Select a paper to view details